Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: Prophylactic or preemptive?

Ming Shen Dai, Tsu Yi Chao

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)95-96
Number of pages2
JournalBreast Cancer Research and Treatment
Volume92
Issue number1
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Fingerprint

Lamivudine
Hepatitis B Surface Antigens
Hepatitis B
Antineoplastic Agents
Antiviral Agents
Breast Neoplasms
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy : Prophylactic or preemptive? / Dai, Ming Shen; Chao, Tsu Yi.

In: Breast Cancer Research and Treatment, Vol. 92, No. 1, 07.2005, p. 95-96.

Research output: Contribution to journalArticle

@article{7e4b9e3fd5fb419aaf0152eb94163079,
title = "Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: Prophylactic or preemptive?",
author = "Dai, {Ming Shen} and Chao, {Tsu Yi}",
year = "2005",
month = "7",
doi = "10.1007/s10549-005-1942-y",
language = "English",
volume = "92",
pages = "95--96",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy

T2 - Prophylactic or preemptive?

AU - Dai, Ming Shen

AU - Chao, Tsu Yi

PY - 2005/7

Y1 - 2005/7

UR - http://www.scopus.com/inward/record.url?scp=21044436475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21044436475&partnerID=8YFLogxK

U2 - 10.1007/s10549-005-1942-y

DO - 10.1007/s10549-005-1942-y

M3 - Article

C2 - 15980997

AN - SCOPUS:21044436475

VL - 92

SP - 95

EP - 96

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -